Solutions

Transforming insoluble actives into stable, scalable nanoparticles across AI-drug discovery, pharma, nutra, and cosmetics. Experience cleaner, simpler, and more effective formulation with FAST Technology.

How We Work

  • Confidential technical exchange (CDA) to share formulation, stability, and safety packets.

  • Feasibility formulations to convert your insoluble actives into FAST nanoparticles in minutes for proof-of-concept.

  • Data package with DLS/ζ, appearance and color (ΔE), and matrix-compatibility checks at 0 h/24 h using preset acceptance criteria.

What You Get

  • Clean Processing: We use only GRAS-status materials to process compounds, keeping compositions simple and label-friendly.

  • Stable, scalable dispersions suited to oral, nasal/dermal, beverage/shot, gel, or rinse formats.
  • A clear path to optimization and scale options aligned to your regulatory plan.

01

Pharmaceuticals

Enable AI model screen for best molecules by bypassing Lipinski’s rule of 5. Unlock challenging BCS II/IV actives with a self-assembling, additive-light approach. FAST forms stable, uniform nanoparticles without carriers or surfactants—reducing formulation complexity while preserving high active content.

Processing Inputs

We use GRAS-status materials during processing; for drug products, we align excipient choices with your regulatory plan (e.g., compendial/IID-listed excipients as appropriate).

Where FAST Fits

Oral

Azoles, statins, fibrates, and CNS actives with low aqueous solubility.

Oncology / Topical / Transdermal

Taxanes & hydrophobic steroids where surfactant burdens or solvent steps are undesirable.

Representative Targets (Non-Exhaustive)

Paclitaxel, docetaxel, itraconazole, fenofibrate, carbamazepine, nifedipine, hydrophobic steroids.

Partnering Path

Begin with a CDA and feasibility batches using our standard CQAs (Z-avg, PDI, ζ).

Regulatory Note

GRAS is a food/use-based concept; pharmaceutical excipients are selected to comply with drug-use requirements in each jurisdiction.

02

Nutraceuticals

A perfect fit for clean-label supplements. FAST uses only GRAS-status materials in processing, producing elegant dispersions of lipophilic actives (e.g., curcumin, resveratrol, quercetin, CoQ10, EC16) for shots, beverages, gummies, or capsules—without polymer/lipid carriers, oils, surfactants, metals, or stabilizers.

What You Get

Consistent handling, high payloads, and straightforward ingredient decks for consumer-friendly products.

Optional Capabilities

Hybrid nanoparticles (two or more nutraceuticals) designed for complementary mechanisms or organ targets.

03

Cosmetics

Help actives cross the skin barrier—without formulation clutter. We use GRAS-status materials to process compounds into uniform nanoparticles suitable for topical systems, while keeping INCI lists simple (no polymer/lipid carriers, surfactants, metals, stabilizers).

Use Cases

Retinol/retinoids (per regulatory status), CoQ10, azelaic acid, salicylic acid, EC16 for creams, serums, and rinses.

Labeling Note

GRAS pertains to processing inputs under U.S. criteria; cosmetic compliance and INCI selection remain product- and market-specific.